PeerView Press Oncology& Hematology CME/CNE/CPE Audio Podcast

http://media.peerviewpress.com/000136/podcast/pvi/xml/album2015/onco_hemato_audio.jpg

PeerView Press is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

0 Likes     0 Followers     1 Subscribers

Sign up / Log in to like, follow, recommend and subscribe!

Website
http://www.peerviewpress.com
Description
PeerView Press is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
Language
🇬🇧 English
last modified
2010-01-26 18:09
last episode published
2018-08-08 23:00
publication frequency
7.35 days
Contributors
PVI, PeerView Institute for Medical Education author  
PeerVoice, 315 Bleecker Street, Suite 182, New York, NY 10014 owner  
Explicit
false
Number of Episodes
122
Rss-Feeds
Detail page
Categories
Science & Medicine

Recommendations


Episodes

Date Thumb Title & Description Contributors
8.08.2018

Johanna C. Bendell, MD - Rethinking Successful Care for Pancreatic Cancer: Therapeutic Sequencing, Innovative Strategies, and Patient Perspectives on Disease Management

Rethinking Successful Care for Pancreatic Cancer: Therapeutic Sequencing, Innovative Strategies, and Patient Perspectives on Disease Management
PVI, PeerView Institute for Medical Education author
6.08.2018

Omid Hamid, MD - Tracing the Arc of Immunotherapy in Melanoma: Insights on the Current Role and Cutting-Edge Uses of Checkpoint Inhibitors for Patient Care

Tracing the Arc of Immunotherapy in Melanoma: Insights on the Current Role and Cutting-Edge Uses of Checkpoint Inhibitors for Patient Care
PVI, PeerView Institute for Medical Education author
30.07.2018

George D. Demetri, MD - Making the TRK to Precision Medicine in Cancer: The Promise of Targeting TRK Fusions in Lung, Breast, GI, and Other Tumors

Making the TRK to Precision Medicine in Cancer: The Promise of Targeting TRK Fusions in Lung, Breast, GI, and Other Tumors
PVI, PeerView Institute for Medical Education author
26.07.2018

Edward B. Garon, MD, MS - Realizing the Potential of Precision Oncology in Lung Cancer—Challenges and Opportunities: Strengthening the Partnership Between Oncology and Pathology to Make the Most of the Latest Diagnostics and Therapies

Realizing the Potential of Precision Oncology in Lung Cancer—Challenges and Opportunities: Strengthening the Partnership Between Oncology and Pathology to Make the Most of the Latest Diagnostics and Therapies
PVI, PeerView Institute for Medical Education author
23.07.2018

Prof Eric Van Cutsem, MD, PhD - The Advent of Immunotherapy in Gastrointestinal Cancers: MasterClass and Practicum on Checkpoint Inhibition and Biomarkers in Colorectal and Gastric Tumors

The Advent of Immunotherapy in Gastrointestinal Cancers: MasterClass and Practicum on Checkpoint Inhibition and Biomarkers in Colorectal and Gastric Tumors
PVI, PeerView Institute for Medical Education author
20.07.2018

David F. McDermott, MD - Rethinking the Management of Advanced RCC in an Evolving Therapeutic Landscape: Focus on New Options and Patient-Centered Treatment Decisions

Rethinking the Management of Advanced RCC in an Evolving Therapeutic Landscape: Focus on New Options and Patient-Centered Treatment Decisions
PVI, PeerView Institute for Medical Education author
18.07.2018

Farhad Ravandi, MD - Making Therapeutic Choices for Diverse AML Populations: Exploring New Science, More Effective Treatment Options, and Impact on Patient Care

Making Therapeutic Choices for Diverse AML Populations: Exploring New Science, More Effective Treatment Options, and Impact on Patient Care
PVI, PeerView Institute for Medical Education author
16.07.2018

Robert Dreicer, MD, MS, MACP, FASCO - Newest Advances and Strategies in Prostate Cancer: Science and Stories on the Evolving Treatment Landscape and Implications for Patient Care

Newest Advances and Strategies in Prostate Cancer: Science and Stories on the Evolving Treatment Landscape and Implications for Patient Care
PVI, PeerView Institute for Medical Education author
13.07.2018

John P. Leonard, MD - The Arrival of Novel Agent Classes in B-Cell Non-Hodgkin Lymphoma: A Personal Guide to Integrating New Therapy Into Patient Care

The Arrival of Novel Agent Classes in B-Cell Non-Hodgkin Lymphoma: A Personal Guide to Integrating New Therapy Into Patient Care
PVI, PeerView Institute for Medical Education author
11.07.2018

Naiyer Rizvi, MD - Emerging Biomarkers, New Targets, and Rational Combinations: Are We on the Verge of the Next Generation of Immuno-Oncology?

Emerging Biomarkers, New Targets, and Rational Combinations: Are We on the Verge of the Next Generation of Immuno-Oncology?
PVI, PeerView Institute for Medical Education author
9.07.2018

Robert Z. Orlowski, MD, PhD - A Personal Look at Innovative Therapy and Meeting Patient Needs in Multiple Myeloma: How I Think, How I Treat

A Personal Look at Innovative Therapy and Meeting Patient Needs in Multiple Myeloma: How I Think, How I Treat
PVI, PeerView Institute for Medical Education author
2.07.2018

Robert Dreicer, MD, MS, MACP, FASCO, MD - Science and Stories: Navigating the Prostate Cancer Landscape: Urologists at the Intersection of Emerging Evidence and Patient Centric Care

Science and Stories: Navigating the Prostate Cancer Landscape: Urologists at the Intersection of Emerging Evidence and Patient Centric Care
PVI, PeerView Institute for Medical Education author
29.06.2018

Charles V. Pollack, MA, MD, FACEP, FAAEM, FAHA, FESC, FCPP - Reversal of Action: Addressing the Unmet Need for Universal Antidotes to Factor Xa Anticoagulants

Reversal of Action: Addressing the Unmet Need for Universal Antidotes to Factor Xa Anticoagulants
PVI, PeerView Institute for Medical Education author
26.06.2018

Gayle Jameson, MSN, ACNP-BC, AOCN - The Pancreatic Cancer Journey: Oncology Nurses Paving the Path to Patient-Centric Care

The Pancreatic Cancer Journey: Oncology Nurses Paving the Path to Patient-Centric Care
PVI, PeerView Institute for Medical Education author
11.06.2018

Matthew D. Hellmann, MD - Moving in Leaps and Bounds Towards Precision Immuno-Oncology: Latest Biomarker Strategies to Guide Patient Selection and Maximize the Potential of Cancer Immunotherapies

Moving in Leaps and Bounds Towards Precision Immuno-Oncology: Latest Biomarker Strategies to Guide Patient Selection and Maximize the Potential of Cancer Immunotherapies
PVI, PeerView Institute for Medical Education author
8.06.2018

Anas Younes, MD - Treatment Evolution in Newly Diagnosed Hodgkin Lymphoma: A Look at the Evidence and Implications for Practice

Treatment Evolution in Newly Diagnosed Hodgkin Lymphoma: A Look at the Evidence and Implications for Practice
PVI, PeerView Institute for Medical Education author
4.06.2018

Richard Kim, MD - A Team Approach to Tackling the Complexities in Later Lines of Therapy for Metastatic Colorectal Cancer

A Team Approach to Tackling the Complexities in Later Lines of Therapy for Metastatic Colorectal Cancer
PVI, PeerView Institute for Medical Education author
1.06.2018

Robin Lachmann, MD, PhD - Diagnosing and Treating Acid Sphingomyelinase Deficiency: The Potential Impact of New Consensus Recommendations and Ongoing Clinical Trials of Emerging Therapies

Diagnosing and Treating Acid Sphingomyelinase Deficiency: The Potential Impact of New Consensus Recommendations and Ongoing Clinical Trials of Emerging Therapies
PVI, PeerView Institute for Medical Education author
28.05.2018

Riccardo Lencioni, MD, FSIR, EBIR - At the Intersection of Local and Systemic Therapy in the Management of Hepatocellular Carcinoma: Preparing for the Next Evolution in Multimodal Treatment

At the Intersection of Local and Systemic Therapy in the Management of Hepatocellular Carcinoma: Preparing for the Next Evolution in Multimodal Treatment
PVI, PeerView Institute for Medical Education author
22.05.2018

Paul Richardson, MD - Integrated Myeloma Management for Transplant-Eligible Patients: The Conjunction of Novel Therapeutic Platforms, Innovative Agents, and HCT

Integrated Myeloma Management for Transplant-Eligible Patients: The Conjunction of Novel Therapeutic Platforms, Innovative Agents, and HCT
PVI, PeerView Institute for Medical Education author
20.05.2018

David Miklos, MD, PhD - New Thinking on GVHD Management in HSCT Recipients: Focus on Underlying Immunology and Innovative Therapeutics

New Thinking on GVHD Management in HSCT Recipients: Focus on Underlying Immunology and Innovative Therapeutics
PVI, PeerView Institute for Medical Education author
18.05.2018

Francisco M. Marty, MD - Refining the Management of CMV in HCT Recipients: What Does the Future Hold?

Refining the Management of CMV in HCT Recipients: What Does the Future Hold?
PVI, PeerView Institute for Medical Education author
11.05.2018

Stephan A. Grupp, MD, PhD - Realizing the Promise of CAR-T Cell Therapy for Leukemia and Lymphoma: Implications for Long-Term Care in the Era of Stem Cell Transplantation

Realizing the Promise of CAR-T Cell Therapy for Leukemia and Lymphoma: Implications for Long-Term Care in the Era of Stem Cell Transplantation
PVI, PeerView Institute for Medical Education author
9.05.2018

Anas Younes, MD - Treatment Innovation in Hodgkin Lymphoma: Integrating New Therapeutic Options With Autologous Transplant Across Clinical Settings

Treatment Innovation in Hodgkin Lymphoma: Integrating New Therapeutic Options With Autologous Transplant Across Clinical Settings
PVI, PeerView Institute for Medical Education author
4.05.2018

Jorge E. Cortes, MD - Novel Induction Options in AML: Assessing the Implications for HCT-Eligible Patients

Novel Induction Options in AML: Assessing the Implications for HCT-Eligible Patients
PVI, PeerView Institute for Medical Education author
2.05.2018

Ghassan Abou-Alfa, MD, MBA - Teaming Up to Improve Outcomes in Advanced Hepatocellular Carcinoma: A Tumor Board Evaluating the Potential of Immunotherapy and Novel Targeted Approaches

Teaming Up to Improve Outcomes in Advanced Hepatocellular Carcinoma: A Tumor Board Evaluating the Potential of Immunotherapy and Novel Targeted Approaches
PVI, PeerView Institute for Medical Education author
27.04.2018

Jonathan E. Rosenberg, MD - Strengthening Our Grip on Immuno-Oncology in Genitourinary Cancers: Understanding Science Through Stories

Strengthening Our Grip on Immuno-Oncology in Genitourinary Cancers: Understanding Science Through Stories
PVI, PeerView Institute for Medical Education author
25.04.2018

Ezra Cohen, MD, FRCPC, FASCO - Solving the Multimodal Puzzle of Head & Neck Cancer in the Immunotherapy Era: How Evidence is Driving Practice Changes

Solving the Multimodal Puzzle of Head & Neck Cancer in the Immunotherapy Era: How Evidence is Driving Practice Changes
PVI, PeerView Institute for Medical Education author
23.04.2018

David F. McDermott, MD - A Master Class on Applying Newer Therapies for Renal Cell Carcinoma: Meeting Real Challenges Through the Advanced Disease Continuum

A Master Class on Applying Newer Therapies for Renal Cell Carcinoma: Meeting Real Challenges Through the Advanced Disease Continuum
PVI, PeerView Institute for Medical Education author
20.04.2018

Naval Daver, MD - Groundbreaking Treatment Options for AML: How to Personalize Patient Care With New and Emerging Therapies

Groundbreaking Treatment Options for AML: How to Personalize Patient Care With New and Emerging Therapies
PVI, PeerView Institute for Medical Education author
18.04.2018

Andrew H. Ko, MD - The Quest to Win Through Science in Pancreatic Cancer: From Sequencing Current Options to Testing Novel Approaches

The Quest to Win Through Science in Pancreatic Cancer: From Sequencing Current Options to Testing Novel Approaches
PVI, PeerView Institute for Medical Education author
13.04.2018

Ghassan Abou-Alfa, MD, MBA - New Options, Emerging Combinations in Advanced Hepatocellular Carcinoma: Are Management Approaches Poised For Transformation?

New Options, Emerging Combinations in Advanced Hepatocellular Carcinoma: Are Management Approaches Poised For Transformation?
PVI, PeerView Institute for Medical Education author
4.04.2018

Naiyer Rizvi, MD - Moving in Leaps and Bounds Towards Precision Immuno-Oncology: Latest Biomarker Strategies to Guide Patient Selection and Maximize the Potential of Cancer Immunotherapies

Moving in Leaps and Bounds Towards Precision Immuno-Oncology: Latest Biomarker Strategies to Guide Patient Selection and Maximize the Potential of Cancer Immunotherapies
PVI, PeerView Institute for Medical Education author
21.03.2018

Mitchell S. Cairo, MD - Journal Insight on VOD/SOS: Expert Views on New Evidence and Guidelines for Disease Management

Journal Insight on VOD/SOS: Expert Views on New Evidence and Guidelines for Disease Management
PVI, PeerView Institute for Medical Education author
19.03.2018

Mark T. Reding, MD - Monitoring Hemostasis in Hemophilia A in an Era of Approved and Emerging Extended Half-Life Factor VIII Therapies: A Visual Guide to Using the Optimal Coagulation Assay and Reagents

Monitoring Hemostasis in Hemophilia A in an Era of Approved and Emerging Extended Half-Life Factor VIII Therapies: A Visual Guide to Using the Optimal Coagulation Assay and Reagents
PVI, PeerView Institute for Medical Education author
9.02.2018

Harry P. Erba, MD, PhD - A Master-Class on Building Better Therapy for AML: Making the Most of an Increasing Number of Innovative Options

A Master-Class on Building Better Therapy for AML: Making the Most of an Increasing Number of Innovative Options
PVI, PeerView Institute for Medical Education author
2.02.2018

Daniel Pallin, MD, MPH - Oncologic Emergencies in the ED: Recognizing and Managing Adverse Reactions Associated With Modern Cancer Therapies—Essential Guidance for Emergency Medicine Specialists

Oncologic Emergencies in the ED: Recognizing and Managing Adverse Reactions Associated With Modern Cancer Therapies—Essential Guidance for Emergency Medicine Specialists
PVI, PeerView Institute for Medical Education author
29.01.2018

Daniel J. DeAngelo, MD, PhD - Redefining Patient Care in Acute Lymphoblastic Leukemia: The Impact of Novel Antibody and Immune Technologies on Clinical Outcomes

Redefining Patient Care in Acute Lymphoblastic Leukemia: The Impact of Novel Antibody and Immune Technologies on Clinical Outcomes
PVI, PeerView Institute for Medical Education author
3.01.2018

Ruben A. Mesa, MD, FACP - Stories From the MPN Casebook: Expert Perspectives on Challenging Treatment Decisions in Polycythemia Vera and Myelofibrosis

Stories From the MPN Casebook: Expert Perspectives on Challenging Treatment Decisions in Polycythemia Vera and Myelofibrosis
PVI, PeerView Institute for Medical Education author
29.12.2017

Guy Young, MD - Illuminating the Role of Shared Decision-Making as the Hemophilia A Management Landscape Continues to Evolve: Progress in Practice

Illuminating the Role of Shared Decision-Making as the Hemophilia A Management Landscape Continues to Evolve: Progress in Practice
PVI, PeerView Institute for Medical Education author
27.12.2017

Naiyer Rizvi, MD - Addressing Unmet Needs in Lung Cancer With Rational Immunotherapy-Based Approaches: Evidence and Practicalities

Addressing Unmet Needs in Lung Cancer With Rational Immunotherapy-Based Approaches: Evidence and Practicalities
PVI, PeerView Institute for Medical Education author
15.12.2017

Robin L. Jones, MD - Contemporary Management Strategies in STS: Targeted and Cytotoxic Treatment Options to Optimize Patient Outcomes

Contemporary Management Strategies in STS: Targeted and Cytotoxic Treatment Options to Optimize Patient Outcomes
PVI, PeerView Institute for Medical Education author
13.12.2017

David L. Rimm, MD, PhD - The Present and the Future of Cancer Immunotherapy Biomarkers: Challenges, Opportunities, and Implications for Pathologists

The Present and the Future of Cancer Immunotherapy Biomarkers: Challenges, Opportunities, and Implications for Pathologists
PVI, PeerView Institute for Medical Education author
11.12.2017

Suresh S. Ramalingam, MD - Orienteering on the Complex Treatment Landscape for EGFR-Mutant NSCLC: Latest Evidence to Guide Clinical Decisions in Everyday Community Practice

Orienteering on the Complex Treatment Landscape for EGFR-Mutant NSCLC: Latest Evidence to Guide Clinical Decisions in Everyday Community Practice
PVI, PeerView Institute for Medical Education author
8.12.2017

Ghassan Abou-Alfa, MD, MBA - The Expanding Role of the Hepatologist in Interdisciplinary Hepatocellular Carcinoma Management: Achieving the Full Potential of Targeted Therapy and Immunotherapy Advances

The Expanding Role of the Hepatologist in Interdisciplinary Hepatocellular Carcinoma Management: Achieving the Full Potential of Targeted Therapy and Immunotherapy Advances
PVI, PeerView Institute for Medical Education author
1.12.2017

Alex Ganetsky, PharmD, BCOP - Pharmacy Practice in the Management of VOD/SOS: Developing Optimal Care Models and Modern Therapeutic Arsenals

Pharmacy Practice in the Management of VOD/SOS: Developing Optimal Care Models and Modern Therapeutic Arsenals
PVI, PeerView Institute for Medical Education author
29.11.2017

Michael Boeckh, MD, PhD - CMV in the Transplant Recipient: At the Crossroads of Current Clinical Challenges and Novel Therapeutic Strategies

CMV in the Transplant Recipient: At the Crossroads of Current Clinical Challenges and Novel Therapeutic Strategies
PVI, PeerView Institute for Medical Education author
27.11.2017

Robert L. Ferris, MD, PhD - Understanding the Impact of Immunotherapy on Head and Neck Cancer: A Look at the Science, Practice, and Future of Multimodal Treatment

Understanding the Impact of Immunotherapy on Head and Neck Cancer: A Look at the Science, Practice, and Future of Multimodal Treatment
PVI, PeerView Institute for Medical Education author
17.11.2017

Naiyer Rizvi, MD - New Opportunities to Improve Outcomes in Locally Advanced, Unresectable Lung Cancer: Integrating Immunotherapy Into a Multimodal Treatment Approach

New Opportunities to Improve Outcomes in Locally Advanced, Unresectable Lung Cancer: Integrating Immunotherapy Into a Multimodal Treatment Approach
PVI, PeerView Institute for Medical Education author
13.11.2017

Lecia V. Sequist, MD, MPH - New Options and Evolving Strategies for Hitting the Target in EGFR-Mutant NSCLC: Navigating the Transitions in the EGFR TKI Treatment Landscape in the Era of Precision Oncology

New Options and Evolving Strategies for Hitting the Target in EGFR-Mutant NSCLC: Navigating the Transitions in the EGFR TKI Treatment Landscape in the Era of Precision Oncology
PVI, PeerView Institute for Medical Education author